Bryan Lu
Family · Burlingame, CANPI 1598510117
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 27.7% of the total. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $35.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$490
- Amgen$432
- Novo Nordisk$319
- AbbVie$297
- Kowa Pharmaceuticals America, Inc.$185
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,921100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $1,085 |
| GSK | 19 | $490 |
| Amgen | 15 | $432 |
| Novo Nordisk | 7 | $319 |
| AbbVie | 8 | $297 |
| Kowa Pharmaceuticals America, Inc. | 4 | $185 |
| Merck | 6 | $152 |
| Pfizer | 2 | $149 |
| Agios Pharmaceuticals, Inc. | 1 | $140 |
| Gilead | 1 | $120 |
| Lilly USA, LLC | 4 | $118 |
| Exact Sciences | 3 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $69 |
| Esperion Therapeutics, Inc. | 3 | $68 |
| Phathom Pharmaceuticals, Inc. | 2 | $62 |
| Astellas Pharma US Inc | 2 | $58 |
| Bayer | 1 | $32 |
| Lundbeck LLC | 1 | $25 |
| Boehringer Ingelheim | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,921 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate | 22 | $162 |
| Lorazepam | 21 | $59 |
Paid to pharmacies, not to this prescriber.
Other family in Burlingame
- Michelle JonesBurlingame$147K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.